Literature DB >> 16887728

Serum procalcitonin in uncomplicated falciparum malaria: a preliminary study.

Bernard Uzzan1, Arezki Izri, Rémy Durand, Michèle Deniau, Olivier Bouchaud, Gérard-Yves Perret.   

Abstract

BACKGROUND: Procalcitonin (PCT) has been found elevated in complicated forms of Plasmodium falciparum malaria. Its usefulness has almost never been assessed in uncomplicated falciparum malaria.
METHOD: We assessed diagnostic and prognostic value of PCT in a prospective series of 25 adults with uncomplicated P. falciparum malaria. Patients originated mainly from western Africa and were infected during a stay back in their native country (19 semi-immune and 6 non-immune subjects; 11 had not received any chemoprophylaxis).
RESULTS: Parasitaemia ranged from 0.01 to 3%. Eighteen patients had their first PCT determined at admission or within 24h thereafter (mean +/- SD: 3.0 +/- 4.6 ng/ml; range: 0.1-19.7). PCT was higher than 0.5 ng/ml in 14 patients (78%), higher than 2 ng/ml in 7 (39%). PCT correlated with parasitaemia (r = 0.53; p = 0.027), not with C-reactive protein (CRP). Delay between first symptoms and diagnosis was much longer among patients with PCT higher than 2 ng/ml than among those with a lower PCT.
CONCLUSION: PCT was often elevated in uncomplicated malaria, especially when delay between first symptoms and diagnosis was long or parasitaemia was high (prognostic marker).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16887728     DOI: 10.1016/j.tmaid.2005.04.003

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  8 in total

Review 1.  Procalcitonin: present and future.

Authors:  H H Liu; J B Guo; Y Geng; L Su
Journal:  Ir J Med Sci       Date:  2015-07-10       Impact factor: 1.568

Review 2.  Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers.

Authors:  Johannes Mischlinger; Caroline Rönnberg; Míriam J Álvarez-Martínez; Silja Bühler; Małgorzata Paul; Patricia Schlagenhauf; Eskild Petersen; Michael Ramharter
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

3.  Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.

Authors:  Fabrice Bruneel; Florence Tubach; Jean-Paul Mira; Sandrine Houze; Sebastien Gibot; Marie-Genevieve Huisse; Bruno Megarbane; Christophe Choquet; Philippe Corne; Eric Peytel; Daniel Villers; Christophe Camus; Olivier Bouchaud; Eric Caumes; Pierre-Marie Girard; Fabrice Simon; Antoine Kalloumeh; Carine Roy; Remy Durand; Jacques Le Bras; Sophie Matheron; Michel Wolff
Journal:  Intensive Care Med       Date:  2016-05-11       Impact factor: 17.440

4.  Immunological, haematological, and clinical attributes of rural and urban malaria: a case-control study in Ghana.

Authors:  Desmond Omane Acheampong; Patrick Adu; Paulina Ampomah; Kwabena Obeng Duedu; Enoch Aninagyei
Journal:  J Parasit Dis       Date:  2021-02-27

5.  Clinical aspects of uncomplicated and severe malaria.

Authors:  Alessandro Bartoloni; Lorenzo Zammarchi
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-05-04       Impact factor: 2.576

6.  Procalcitonin levels in children affected by severe malaria compared to those with uncomplicated malaria in the absence of bacterial infection: a cross-sectional study.

Authors:  Jean-Claude Katte; Kiya Penanje; Batakeh B Agoons; Eric Noel Djahmeni; Sharon Mbacham-Ngwafor; Vicky Jocelyne Ama Moor; Paul Koki; Wilfred Mbacham
Journal:  Trop Dis Travel Med Vaccines       Date:  2022-03-15

7.  Procalcitonin as a Candidate Biomarker for Malarial Infection and Severe Malaria: A Meta-Analysis.

Authors:  Aongart Mahittikorn; Kwuntida Uthaisar Kotepui; Wanida Mala; Polrat Wilairatana; Manas Kotepui
Journal:  Int J Environ Res Public Health       Date:  2022-09-09       Impact factor: 4.614

8.  Procalcitonin as a biomarker for severe Plasmodium falciparum disease: a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers with imported malaria.

Authors:  Dennis A Hesselink; Jan-Steven Burgerhart; Hanna Bosmans-Timmerarends; Pieter Petit; Perry J J van Genderen
Journal:  Malar J       Date:  2009-09-01       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.